Autopsy report · NCT03969511

Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke

“Following the interim analysis, the planned number of staff (208) will not be sufficient to achieve the main objective”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 3 years 9 months before it stopped.
• 120 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Central Hospital, Nancy, France

Sponsor type

University, hospital or other

Conditions

Acute Ischemic Stroke

Interventions

direct angio-suite admission; standard management

Participants

120

Sites

1

Countries

France

Trials that died the same way

• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack
  “In view of the continuing insufficient patient recruitment in the study due to the difficult epidemiological situation and the need for rational allocation of company resources, as well as based on the results of the interim analysis.” (58% match in meaning)
• A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy
  “Insufficient Staff” (58% match in meaning)
• Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder
  “The sample size of the planned interims analysis was achieved” (57% match in meaning)
• 24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery
  “Due to staff departures we were unable to execute this study” (57% match in meaning)
• The Dallas Hereditary Spherocytosis Cohort Study
  “Insufficient staff to continue pursuing project” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.